Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infection.
Abstract
BACKGROUND: Since the introduction of new recommendations for the treatment of latent tuberculosis infection (LTB1) disregarding age as a limitation, increasing numbers of older individuals are expected to undergo treatment with isoniazid for the preventi
This paper has been withdrawn.